Nordic Bioproducts Group Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B
- Investors
-
4
Nordic Bioproducts Group General Information
Description
Developer of intelligent biotechnologies designed to redesign cellulose into high-value bioproducts. The company's biotechnologies help industries to combat the effects of global warming with innovative bioproducts and bioproduction technologies that work with food, pharma, plastics, and textiles, and create a healthy, carbon-neutral, and sustainable future for the planet and profit for the businesses, enabling industries to create bioproducts with positive economic, environmental, and social impact.
Contact Information
Website
www.nordicbioproducts.fiCorporate Office
- Tietotie 2
- 02150 Espoo
- Finland
Corporate Office
- Tietotie 2
- 02150 Espoo
- Finland
Nordic Bioproducts Group Timeline
Nordic Bioproducts Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 19-Jan-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 30-Mar-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-Aug-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 29-Oct-2021 | $1.45M | $1.45M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Nordic Bioproducts Group Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Series A | 264 | $964.14 | $964.14 | 1x | $964.14 | 2.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nordic Bioproducts Group Patents
Nordic Bioproducts Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003424-A1 | Novel reactor system to produce microcrystalline cellulose | Pending | 28-Jun-2024 | ||
| WO-2025242961-A1 | Pressure control system, method and apparatus for controlling pressure | Pending | 20-May-2024 | ||
| WO-2023144448-A1 | Low viscosity emulsions prepared from microcrystalline cellulose | Inactive | 27-Jan-2022 | ||
| CA-3154636-A1 | Homogeneous fiber product based on bio-oil and / or water and method for their production | Pending | 16-Sep-2019 | ||
| EP-4031614-A1 | Homogeneous fiber product based on bio-oil and/or water and method for their production | Inactive | 16-Sep-2019 | C08L1/04 |
Nordic Bioproducts Group Signals
Nordic Bioproducts Group Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Oji Holdings | Holding Company | Minority | ||
| Taaleri Bioindustry | Growth/Expansion | Minority | ||
| CMPC Ventures | Corporate Venture Capital | Minority | ||
| Aalto University | University |
Nordic Bioproducts Group FAQs
-
When was Nordic Bioproducts Group founded?
Nordic Bioproducts Group was founded in 2019.
-
Where is Nordic Bioproducts Group headquartered?
Nordic Bioproducts Group is headquartered in Espoo, Finland.
-
What is the size of Nordic Bioproducts Group?
Nordic Bioproducts Group has 30 total employees.
-
What industry is Nordic Bioproducts Group in?
Nordic Bioproducts Group’s primary industry is Other Materials.
-
Is Nordic Bioproducts Group a private or public company?
Nordic Bioproducts Group is a Private company.
-
What is Nordic Bioproducts Group’s current revenue?
The current revenue for Nordic Bioproducts Group is .
-
How much funding has Nordic Bioproducts Group raised over time?
Nordic Bioproducts Group has raised $38.7M.
-
Who are Nordic Bioproducts Group’s investors?
Oji Holdings, Taaleri Bioindustry, CMPC Ventures, and Aalto University have invested in Nordic Bioproducts Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process